Uniretic™/Femipres™ Plus/Perdix™ Plus (hypertension)

Other available trademarks: Univasc™, Moex®, Cardiotensin®, Primox®

Uniretic™/Femipres™ Plus/Perdix™ Plus (moexipril hydrochloride, hydrochlorothiazide) is indicated for the treatment of essential hypertension when additional blood pressure control is required over moexipril hydrochloride or hydrochlorothiazide (HCTZ) monotherapy. This fixed dose combination is indicated in patients whose blood pressure has been stabilised on the individual components given in the same proportions.

Uniretic™/Femipres™ Plus/Perdix™ Plus may be prescribed for use in adults and elderly.